Viemed Healthcare, Inc. (VMD)

NASDAQ: VMD · Real-Time Price · USD
9.79
+0.13 (1.35%)
Apr 27, 2026, 2:30 PM EDT - Market open
Market Cap377.92M +43.8%
Revenue (ttm)270.28M +20.5%
Net Income14.93M +32.6%
EPS0.37 +32.1%
Shares Out 38.60M
PE Ratio26.53
Forward PE20.45
Dividendn/a
Ex-Dividend Daten/a
Volume316,939
Open9.60
Previous Close9.66
Day's Range9.60 - 9.98
52-Week Range5.93 - 10.06
Beta1.16
Analystsn/a
Price Targetn/a
Earnings DateMay 5, 2026

About VMD

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ... [Read more]

Sector Healthcare
Founded 2006
Employees 1,382
Stock Exchange NASDAQ
Ticker Symbol VMD
Full Company Profile

Financial Performance

In 2025, Viemed Healthcare's revenue was $270.28 million, an increase of 20.52% compared to the previous year's $224.26 million. Earnings were $14.93 million, an increase of 32.57%.

Financial Statements

News

Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / April 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chro...

5 days ago - Accesswire

Viemed Healthcare Transcript: Sidoti March Small-Cap Virtual Conference

Home-based care platform continues rapid, profitable growth through service diversification, technology, and disciplined M&A. Regulatory clarity and favorable reimbursement trends support expansion, with strong momentum in sleep, maternal health, and staffing divisions.

5 weeks ago - Transcripts

Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19

LAFAYETTE, LA / ACCESS Newswire / March 16, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chro...

5 weeks ago - Accesswire

Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 4Q 2025

Dallas, Texas--(Newsfile Corp. - March 11, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).

6 weeks ago - Newsfile Corp

Viemed Healthcare Earnings Call Transcript: Q4 2025

Record revenue and Adjusted EBITDA were achieved in 2025, driven by strong growth in sleep and maternal health, with free cash flow more than doubling year-over-year. 2026 guidance projects 17% revenue growth and stable margins, supported by a diversified platform and robust capital allocation.

7 weeks ago - Transcripts

Viemed Healthcare Announces Record 2025 Financial Results

LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chron...

7 weeks ago - Accesswire

Viemed Healthcare Announces 2026 Share Repurchase Program

LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chron...

7 weeks ago - Accesswire

Viemed Healthcare Announces Year End 2025 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / February 24, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and c...

2 months ago - Accesswire

Viemed Healthcare Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

A diversified home healthcare provider has evolved from a ventilator-focused business to a multi-segment model, leveraging clinical data, technology, and targeted acquisitions for growth. Recurring revenue streams and stable margins support a positive outlook, with expansion in respiratory and maternal health planned for 2026.

3 months ago - Transcripts

Stonegate Capital Partners Initiates Coverage on Viemed Healthcare, Inc. (VMD)

Dallas, Texas--(Newsfile Corp. - January 6, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners initiates their coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).

3 months ago - Newsfile Corp

Viemed Healthcare Earnings Call Transcript: Q3 2025

Record revenue and strong growth across diversified service lines, with sleep and maternal health segments accelerating and the Lehans acquisition boosting scale. Guidance narrowed with improved EBITDA margin outlook, while disciplined capital allocation and innovation drive operational efficiency.

6 months ago - Transcripts

Viemed Healthcare Announces Third Quarter 2025 Financial Results

LAFAYETTE, LA / ACCESS Newswire / November 5, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment ...

6 months ago - Accesswire

Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / October 21, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, tod...

6 months ago - Accesswire

Viemed Healthcare Transcript: LD Micro Main Event XIX Investor Conference

Focused on complex respiratory and sleep therapy, the company has achieved consistent organic growth, expanding its product mix and geographic reach while maintaining profitability. Recent acquisitions and technology investments support a resilient, scalable model and strong clinical outcomes.

6 months ago - Transcripts

Viemed Healthcare Announces Completion of Share Repurchase Program

LAFAYETTE, LA / ACCESS Newswire / September 23, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, t...

7 months ago - Accesswire

Viemed Healthcare Earnings Call Transcript: Q2 2025

Q2 2025 saw 14.7% revenue growth, driven by organic expansion and strong performance in core ventilation, sleep therapy, and resupply. Guidance for 2025 was raised following the Lehan acquisition, with continued margin improvement and robust liquidity supporting growth.

9 months ago - Transcripts

Viemed Healthcare Announces Second Quarter 2025 Financial Results

LAFAYETTE, LA / ACCESS Newswire / August 6, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment an...

9 months ago - Accesswire

Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / July 22, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and...

9 months ago - Accesswire

Viemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial Results

LAFAYETTE, LA / ACCESS Newswire / July 2, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and...

10 months ago - Accesswire

Viemed Healthcare Transcript: The 15th Annual East Coast IDEAS Conference

A national in-home respiratory care provider reported strong organic growth, expanding through targeted acquisitions and technology integration. Financial performance remains robust, with double-digit revenue and net income growth, a new share buyback, and continued focus on underserved markets.

11 months ago - Transcripts

Viemed Healthcare Earnings Call Transcript: Q1 2025

Q1 results surpassed expectations with 16.9% revenue growth and a 26% rise in adjusted EBITDA. Guidance for 2025 was raised, and the Lehan acquisition is set to expand market reach and diversify offerings. No net debt and strong free cash flow position support continued growth.

1 year ago - Transcripts

Viemed Healthcare Announces First Quarter 2025 Financial Results

LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment s...

1 year ago - GlobeNewsWire

Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and...

1 year ago - GlobeNewsWire

Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details

LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment...

1 year ago - GlobeNewsWire

Viemed Healthcare Earnings Call Transcript: Q4 2024

Record revenue and patient growth in 2024 were driven by strong vent and sleep segments, with adjusted EBITDA up 19% year-over-year. 2025 guidance projects 16% revenue growth and 10% adjusted EBITDA growth, supported by a robust balance sheet and expanding behavioral health services.

1 year ago - Transcripts